In drug development, “proof-of-concept” refers to a part of the clinical study that aims to proof the therapeutic concept.
Synonyms
PoC
Detailed description
The “Proof-of-concept” study takes place at the beginning of the clinical phase when a substance has already demonstrated its efficacy in animal studies and preliminary investigations concerning its safety have been successful. Its purpose is to show whether the substance of interest does actually influence disease-relevant mechanisms.
At the DZIF, EBV research has been ongoing for years. Now a promising vaccine candidate is passing from the laboratory to quality assured production. Subsequently, preclinical and early clinical
Many common antibiotics are increasingly losing their effectiveness against multi-resistant pathogens, which are becoming ever more prevalent. Bacteria use natural means to acquire mechanisms that
Worldwide, approximately 260 million people suffer from chronic hepatitis B which is currently incurable. However, there is now a shimmer of hope on the horizon as scientists at the DZIF have
